Search Results - "Booms, P"

Refine Results
  1. 1
  2. 2

    Potential lack of “standardized” processing techniques for production of allogeneic and xenogeneic bone blocks for application in humans by Ghanaati, S., Barbeck, M., Booms, P., Lorenz, J., Kirkpatrick, C.J., Sader, R.A.

    Published in Acta biomaterialia (01-08-2014)
    “…[Display omitted] In the present study, the structure of two allogeneic and three xenogeneic bone blocks, which are used in dental and orthopedic surgery, were…”
    Get full text
    Journal Article
  3. 3

    Platelet-rich fibrin secretome induces three dimensional angiogenic activation in vitro by Herrera-Vizcaíno, C, Dohle, E, Al-Maawi, S, Booms, P, Sader, R, Kirkpatrick, C J, Choukroun, J, Ghanaati, S

    Published in European cells & materials (09-04-2019)
    “…Different tissue engineering techniques are used to support rapid vascularisation. A novel technique is the use of platelet-rich fibrin (PRF), an autologous…”
    Get full text
    Journal Article
  4. 4

    The molecular genetics of Marfan syndrome and related disorders by Robinson, P N, Arteaga-Solis, E, Baldock, C, Collod-Béroud, G, Booms, P, De Paepe, A, Dietz, H C, Guo, G, Handford, P A, Judge, D P, Kielty, C M, Loeys, B, Milewicz, D M, Ney, A, Ramirez, F, Reinhardt, D P, Tiedemann, K, Whiteman, P, Godfrey, M

    Published in Journal of Medical Genetics (01-10-2006)
    “…Marfan syndrome (MFS), a relatively common autosomal dominant hereditary disorder of connective tissue with prominent manifestations in the skeletal, ocular,…”
    Get full text
    Journal Article Book Review
  5. 5

    Monocyte preseeding leads to an increased implant bed vascularization of biphasic calcium phosphate bone substitutes via vessel maturation by Barbeck, M., Unger, R. E., Booms, P., Dohle, E., Sader, R. A., Kirkpatrick, C. J., Ghanaati, S.

    “…The present study analyzes the influence of the addition of monocytes to a biphasic bone substitute with two granule sizes (400–700 μm and 500–1000 μm). The…”
    Get full text
    Journal Article
  6. 6

    Genetic variation in RYR1 and malignant hyperthermia phenotypes by Carpenter, D., Robinson, R.L., Quinnell, R.J., Ringrose, C., Hogg, M., Casson, F., Booms, P., Iles, D.E., Halsall, P.J., Steele, D.S., Shaw, M.-A., Hopkins, P.M.

    Published in British journal of anaesthesia : BJA (01-10-2009)
    “…Malignant hyperthermia (MH) is associated, in the majority of cases, with mutations in RYR1, the gene encoding the skeletal muscle ryanodine receptor. Our…”
    Get full text
    Journal Article
  7. 7

    Assessing the pathogenicity of RYR1 variants in malignant hyperthermia by Merritt, A., Booms, P., Shaw, M.-A., Miller, D.M., Daly, C., Bilmen, J.G., Stowell, K.M., Allen, P.D., Steele, D.S., Hopkins, P.M.

    Published in British journal of anaesthesia : BJA (01-04-2017)
    “…Missense variants in the ryanodine receptor 1 gene (RYR1) are associated with malignant hyperthermia but only a minority of these have met the criteria for use…”
    Get full text
    Journal Article
  8. 8

    P24 Biomaterial-based tissue-like constructs for assessing effects of vismodegib on soft and hard tissue by Booms, P, Ghanaati, S, Sader, R

    Published in Oral oncology (01-05-2015)
    “…This study is the first to show the effect of vismodegib on healthy and tumour cells. Such results are vey important when considering the resection margin…”
    Get full text
    Journal Article
  9. 9

    Small-sized granules of biphasic bone substitutes support fast implant bed vascularization by Barbeck, M, Dard, M, Kokkinopoulou, M, Markl, J, Booms, P, Sader, Ra, Kirkpatrick, Cj, Ghanaati, S

    Published in Biomatter (Austin, TX) (2015)
    “…The present study investigated the influence of granule size of 2 biphasic bone substitutes (BoneCeramic® 400-700 μm and 500-1000 μm) on the induction of…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    The molecular pathogenesis of the Marfan syndrome by Robinson, P N, Booms, P

    “…The Marfan syndrome (MFS) is an autosomal dominant heritable disorder of connective tissue with highly variable clinical manifestations including aortic…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Epigenetic allele silencing and variable penetrance of malignant hyperthermia susceptibility by Robinson, R.L., Carpenter, D., Halsall, P.J., Iles, D.E., Booms, P., Steele, D., Hopkins, P.M., Shaw, M.-A.

    Published in British journal of anaesthesia : BJA (01-08-2009)
    “…Tissue-specific monoallelic silencing of the RYR1 gene has been proposed as an explanation for variable penetrance of dominant RYR1 mutations in malignant…”
    Get full text
    Journal Article
  17. 17

    Analysis of RYR1 Haplotype Profile in Patients with Malignant Hyperthermia by Carpenter, D., Morris, A., Robinson, R. L., Booms, P., Iles, D., Halsall, P. J., Steele, D., Hopkins, P. M., Shaw, M.‐A.

    Published in Annals of human genetics (01-01-2009)
    “…Summary This study represents a new approach to characterising patients at risk of malignant hyperthermia (MH) through the use of a recently published method…”
    Get full text
    Journal Article
  18. 18

    Human Genome and Diseases:¶The molecular pathogenesis of the Marfan syndrome by Robinson, P.N., Booms, P.

    “…The Marfan syndrome (MFS) is an autosomal dominant heritable disorder of connective tissue with highly variable clinical manifestations including aortic…”
    Get full text
    Journal Article
  19. 19

    Differential effect of FBN1 mutations on in vitro proteolysis of recombinant fibrillin-1 fragments by BOOMS, P, TIECKE, F, ROSENBERG, T, HAGEMEIER, C, ROBINSON, P. N

    Published in Human genetics (01-09-2000)
    “…Mutations in the fibrillin-1 gene (FBN1) cause Marfan syndrome (MFS), an autosomal dominant disorder of connective tissue with highly variable clinical…”
    Get full text
    Journal Article
  20. 20

    The EAAT2 (GLT-1) gene in motor neuron disease: absence of mutations in amyotrophic lateral sclerosis and a point mutation in patients with hereditary spastic paraplegia by Meyer, Thomas, Münch, Christoph, Völkel, Helge, Booms, Patrick, Ludolph, Albert C

    “…OBJECTIVES To investigate if sequence alterations of the excitatory amino acid transporter gene EAAT2 (GLT-1) may be a contributory factor to the pathogenesis…”
    Get full text
    Journal Article